Calcipotriene And Betamethasone Dipropionate Ointment
Product Images NDC 66993-938

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Calcipotriene And Betamethasone Dipropionate (NDC 66993-938). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Prasco Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Calcipotriene 01)

FDA Label Image

Chemical Structure (Calcipotriene 02)

FDA Label Image

Principal Display Panel (60 g Tube Carton)

This is a pharmaceutical ointment containing calcipotriene hydrate and betamethasone dipropionate. It is intended to be applied topically as directed by a physician, for conditions that the physician deems treatable by this medication. The ointment should be stored within a temperature range of 20°C to 25°C (68°F to 77°F). It is distributed by Prasco Laboratories and the manufacturer is LEO Laboratories L, based in Dublin, Ireland.*

FDA Label Image

Calcipotriene 04

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.